Organization · Private Equity

GL Capital Group

GL Capital Group is a private equity firm based in China, specializing in value investments within the healthcare sector, particularly in pharmaceuticals and medical enterprises. Founded in 2010, it focuses on buyouts and significant minority opportunities.

Private EquityFunder

Overview

What GL Capital Group does

What GL Capital Group is

GL Capital Group is a private equity firm based in China, specializing in value investments within the healthcare sector, particularly in pharmaceuticals and medical enterprises. Founded in 2010, it focuses on buyouts and significant minority opportunities.

How it participates in the startup ecosystem

The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.

Operational profile

Organization status and context

Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.

Operational status
Active
Organization type
Private Equity
Founded
Founded in 2010
Approximate age
About 16 years
Structured capabilities
Funder
Last reviewed
March 3, 2026

Official channels

Find GL Capital Group elsewhere

Open the official website or a supported primary organization account.

Capability profile

GL Capital Group as a funder

Investment thesis

GL Capital specializes in investments within the healthcare industry, targeting companies with sustainable competitive advantages. The firm aims to collaborate with visionary management teams and pursues both mergers and acquisitions as well as growth equity opportunities.

Focus narrative

GL Capital specializes in investments within the healthcare industry, including pharmaceuticals, medical services, IVD (in vitro diagnostics), and CXO (contract research organization) sectors. The firm targets companies with sustainable competitive advantages and aims to collaborate with visionary management teams. Their investment strategy encompasses both mergers and acquisitions as well as growth equity opportunities.

Availability

Currently deploying
Not published

Portfolio and track record

Recorded portfolio count
99

Portfolio context

GL Capital has invested in 99 companies across the healthcare value chain. Notable portfolio companies include MaiXin Biotechnology, SaiSheng Pharmaceuticals, XiHua Testing, Kanglong Chemical, YouDe Medical, and XuDong HaiPu.

Connected ecosystem

Continue from GL Capital Group

These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.

Common questions

What to know about GL Capital Group

Upseed classifies GL Capital Group under the Private Equity organization type. Its current public profile includes funder capabilities.

Next step

Keep comparing startup organizations

Return to the organization index or continue through a verified sector, place, peer, or program connected to this profile.

Source and update disclosure

Know what this page is based on

Source basis

Public organization and program material, official websites, and structured Upseed records.

Last reviewed

March 3, 2026

Known limits

Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.

Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.